Table 1 summarizes the effects of NO3−-NO2− therapy on glucose and insulin homeostasis, and diabetes-induced cardiometabolic disorders in animal models of T2DM. More details about the favorable metabolic effects of NO3− and NO2− can be found in published reviews [2,3,61]. The gene discussed is INS; the disease is type 2 diabetes mellitus.